Safety and Efficacy of DCB for the Treatment of SFA Ischemic Vascular Disease in Patients With TASC C and D Lesions
Clinical trial NCT03129750 · UNKNOWN
Trial details
- NCT number
- NCT03129750
- Sponsor
- Ettore Sansavini Health Science Foundation
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-09-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.